Artelo Biosciences, Inc. (ARTL)
7.04
-0.80
(-10.20%)
USD |
NASDAQ |
Apr 02, 16:00
7.08
+0.04
(+0.57%)
After-Hours: 20:00
Artelo Biosciences Total Liabilities (Quarterly) : 4.073M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 658.74M |
| GlucoTrack, Inc. | 5.01M |
| Ovid Therapeutics, Inc. | 20.27M |
| Apellis Pharmaceuticals, Inc. | 705.11M |
| Gossamer Bio, Inc. | 295.01M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.801M |
| Shareholders Equity (Quarterly) | -1.272M |
| Debt to Equity Ratio | -0.533 |
| Current Ratio | 0.1719 |
| Net Debt Paydown Yield | -4.60% |